Depression drug may mend blood vessels damaged by preeclampsia

NCT ID NCT07715669

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

Women who had preeclampsia are at higher risk for both depression and heart disease later in life. This study investigates whether antidepressant medication can improve blood vessel function in these women. Researchers will measure skin blood vessel responses in 40 women, comparing those with and without a history of preeclampsia and depression. The goal is to understand the link between depression treatment and cardiovascular health after preeclampsia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
paroxetine hydrochloride and ascorbic acid (vitamin C) delivered locally to the skin via microdialysis
What this could lead to
If successful, this research could point toward using antidepressant therapy to lower heart disease risk in women who had preeclampsia.
What could go wrong
This is a very early, small study (40 participants) measuring only short-term skin blood vessel responses, not actual heart disease outcomes. Results may not translate to long-term cardiovascular benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Iowa

    RECRUITING

    Iowa City, Iowa, 52242-3521, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.